Study variable | Number of patients (N) | Percentages (%) |
---|---|---|
Age (in years) | Â | Â |
≤45 | 97 | 68.3 |
>45 | 45 | 31.7 |
Sex | Â | Â |
Male | 98 | 69.0 |
Female | 44 | 31.0 |
Duration of symptoms (in weeks) | Â | Â |
≤16 | 17 | 12.0 |
>16 | 125 | 88.0 |
HBsAg | Â | Â |
Positive | 94 | 66.2 |
Negative | 48 | 33.8 |
HCV antibody | Â | Â |
Positive | 24 | 16.9 |
Negative | 118 | 83.1 |
HIV status | Â | Â |
Positive | 13 | 9.2 |
Negative | 129 | 90.8 |
HCC type | Â | Â |
Multiple discrete lesions | 70 | 49.3 |
Diffuse lesions | 52 | 26.6 |
Solitary lesions | 20 | 14.1 |
Solitary lesions | Â | Â |
>10Â cm | 12 | 60.0 |
5-10Â cm | 5 | 25.0 |
<5Â cm | 3 | 15.0 |
Okuda stage | Â | Â |
I | - | - |
II | 34 | 23.2 |
III | 108 | 76.8 |
Child-Pugh class | Â | Â |
A | - | - |
B | 39 | 27.5 |
C | 103 | 72.5 |
Histopathological grade | Â | Â |
Well differentiated | 84 | 59.2 |
Moderately differentiated | 18 | 12.7 |
Poorly differentiated | 40 | 28.1 |